Associate Director, Business Continuity & Crisis Management
Nathan Schoenkin is a seasoned professional at AstraZeneca with nearly 15 years of specialized expertise in emergency management, business continuity planning, operational resilience, engineering, crisis management, and critical infrastructure protection. In July 2025, he was elected to serve as the leader of the Operational Resilience Special Interest Group (SIG) for a two-year term.
Throughout his career, Nathan has delivered comprehensive strategic and operational support to a diverse portfolio of public and private sector organizations. His client experience spans major corporations and federal agencies, including AstraZeneca, the Financial Industry Regulatory Authority (FINRA), the U.S. Department of Transportation (DOT), the Pipeline and Hazardous Materials Safety Administration (PHMSA), the General Services Administration (GSA), the National Nuclear Security Administration (NNSA), and Tiffany & Co.
Nathan's academic foundation includes a Bachelor of Science in Mechanical Engineering from the University of Maryland, a Master of Engineering Management with a specialized focus in Crisis, Emergency, and Risk Management from The George Washington University, and a Certificate in Cyber Security Policy from the University of Maryland University College.